Prognostic Value of Novel CARWL Score in Stage IIIC Non-Small-Cell Lung Cancer Patients Undergoing Concurrent Chemoradiotherapy.

MLA

Topkan, Erkan, et al. “Prognostic Value of Novel CARWL Score in Stage IIIC Non-Small-Cell Lung Cancer Patients Undergoing Concurrent Chemoradiotherapy.” Canadian Respiratory Journal, vol. 2024, June 2024, p. 2803044. EBSCOhost, https://doi.org/10.1155/2024/2803044.

APA

Topkan, E., Kucuk, A., Ozturk, D., Ozkan, E. E., Besen, A. A., Pehlivan, B., & Selek, U. (2024). Prognostic Value of Novel CARWL Score in Stage IIIC Non-Small-Cell Lung Cancer Patients Undergoing Concurrent Chemoradiotherapy. Canadian Respiratory Journal, 2024, 2803044. https://doi.org/10.1155/2024/2803044

Chicago

Topkan, Erkan, Ahmet Kucuk, Duriye Ozturk, Emine Elif Ozkan, Ali Ayberk Besen, Berrin Pehlivan, and Ugur Selek. 2024. “Prognostic Value of Novel CARWL Score in Stage IIIC Non-Small-Cell Lung Cancer Patients Undergoing Concurrent Chemoradiotherapy.” Canadian Respiratory Journal 2024 (June): 2803044. doi:10.1155/2024/2803044.